France's LEEM gives 200,000 euros for rare disease research

11 December 2006

France's drug industry trade association (LEEM) has announced the donation of 200,000 euros ($262,400) to a consortium of charitable organizations, the platform for rare diseases (PRMR), on the occasion of the 20th Telethon, an annual series of television-centered charity fundraising efforts.

The LEEM also noted the improvements that have resulted from the December 1999 European Union regulation on orphan drugs, which has already generated 29 new products. In addition, the LEEM says that 885 rare diseases are the subject of at least one European research project.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight